Enhancement Medical got the FDA’s highest-risk recall warning over manufacturing concerns about the company’s Expression Intranasal Splint.
Originally affecting a limited lot of the Expression product, the recall now includes every unit of the gel since Enhancement began manufacturing in 2012. The company said it launched the recall because it can’t guarantee that the products were manufactured appropriately, especially after receiving reports consistent with too much hyaluronic acid in the product.
Help employers find you! Check out all the jobs and post your resume.
